Arvinas Androgen Receptor, Inc.

Quick facts

Phase 1 pipeline

• ARV-110 in Combination with Abiraterone · Oncology
  Androgen receptor inhibitor

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Arvinas Androgen Receptor, Inc. portfolio CI brief
• Arvinas Androgen Receptor, Inc. pipeline updates RSS